Laura K. Aguilar serves as Executive at Candel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Laura K. Aguilar has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 6, 2022 involved exercising options for 171,335 shares valued at $250.1K.
Laura K. Aguilar currently holds 1,102,374 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laura K. Aguilar has been a net neutral trader of CADL stock. They have purchased $0 and sold $0 worth of shares.
Laura K. Aguilar's most recent insider trade was on May 6, 2022, when they sold 171,335 shares at $1.46 per share.
Get notified when new Form 4 filings are submitted
| 68,534 |
| $3.65 |
| Discretionary |
| Jul 29, 2021 | CADL | $0 | Conversion | 56,096 | $N/A | Discretionary |